World Wires · story 4979 · unverified · 1 source(s)

Caspian Therapeutics Unveils KO-7246 at EASD

Caspian Therapeutics presented KO-7246 as a menin inhibitor for diabetes, demonstrating cell mass regeneration in models.

Open in the desk

Coverage

• Caspian Therapeutics Unveils KO-7246 at EASD GlobeNewswire: public companies · tier D · clear net · 2026-09-29 09:15 UTC

What this site indexes